Inhibrx, Inc. Common Stock
INBX
INBX was delisted on the 29th of May, 2024.
55 hedge funds and large institutions have $326M invested in Inhibrx, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 12
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
8% more funds holding
Funds holding: 51 → 55 (+4)
36% less capital invested
Capital invested by funds: $513M → $326M (-$187M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.7M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.48M |
| 3 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$4.1M |
| 4 |
BlackRock
New York
|
+$3.06M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$70.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$959K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$889K |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$687K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$323K |
INBX Hedge Fund Activity: Q1 2021 in Review
55 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q1 2021, worth a combined $326M — down 36% from $513M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new INBX positions and 5 closed out — a net gain of 4 holders — while 24 added to existing stakes and 12 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $57.7M. The largest seller was RA Capital Management, exiting entirely with an estimated $70.2M sold.
- 55 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q1 2021, up from 51 in Q4 2020.
- Funds reported $326M of Inhibrx, Inc. Common Stock stock for Q1 2021, down 36% quarter-over-quarter.
- 9 funds opened new Inhibrx, Inc. Common Stock positions in Q1 2021 and 5 closed out, a net change of +4 holders.
- The largest Inhibrx, Inc. Common Stock buyer in Q1 2021 was Wellington Management Group, an estimated $57.7M added.
- The largest Inhibrx, Inc. Common Stock seller in Q1 2021 was RA Capital Management, an estimated $70.2M sold.
Based on aggregated 13F filings for Q1 2021.